Human resources for the approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States

Canadian Journal of Clinical Pharmacology

Volumn 9, Issue 2, 2002, Pages 73-78

  Rawson, Nigel S B ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Center for Health Care Policy and Evaluation   (United States)

Author keywords

Drug approval; Human resources

Indexed keywords

AUSTRALIA; CANADA; COMPARATIVE STUDY; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; PERFORMANCE; PERSONNEL MANAGEMENT; RESOURCE ALLOCATION; REVIEW; STAFF; SWEDEN; TIME; UNITED KINGDOM; UNITED STATES;

EID: 0036592897     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Feds slagged for not approving AIDS drug
2. AIDS activists condemn slow drug-approval process
3. Canada needs faster drug approvals, fewer addict prosecutions, AIDS society says
4. First to start, last to finish: Approvals track record is poor
5. Loosening the cap on drug approvals
6. Prescription for Performance: A National Summit
7. Drug review in Canada: A comparison with Australia, Sweden, the United Kingdom and the United States
8. Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998
9. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998
10. New challenges in quality control and licensure: Regulation
11. The Prescription Drug User Fee Act of 1992 and the new drug development process